✦ LIBER ✦

P71 Epirubicin (EPI) and vinorelbine (VNR): A new promising combination for primary systemic chemotherapy for breast cancer

✍ Scribed by C. Nisticò; A. de Matteis; R. Valenza; D. Quattrocchio; C. Garufi; A. Maiorino; M. Cremonesi; E. Rossi; B. Agostara; B. Lazzaro; A.M. Borzacchini; A.M. D'Ottavio; R. Mencacci; E. Terzoli

Book ID: 117665506
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 145 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)89288-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicina (EPI) and vinorelbine (VNR):

Epirubicina (EPI) and vinorelbine (VNR): High activity, dose dense regimen for primary breast cancer

✍ C. Nisticò; A. de Matteis; R. Valenza; D. Quattrocchio; A. Farris; A. Vaccaro; M 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Primary medical chemotherapy with contin

Primary medical chemotherapy with continuous infusional 5-fu (F), epirubicin (E) and cisplatin (P) for large operable breast cancer: a very active new regimen

✍ I.E. Smith; A.L. Jones; G. Walsh; M. Baum; S. Ebbs; N. Sacks 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Perioperative chemotherapy (CT) with ind

Perioperative chemotherapy (CT) with induction sequential epirubicin (EPI) and docetaxel (DOC) followed by surgery and DOC or gemcitabine/vinorelbine (GEN) with radiotherapy for locally advanced breast cancer (LABC)

✍ A. Ardavanis; P. Kountourakis; I. Missitzis; D. Doufexis; S. Malliou; V. Zobolas 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Primary medical (neoadjuvant) chemothera

Primary medical (neoadjuvant) chemotherapy with continuous infusional 5-FU (F), epirubicin (E) and cisplatin (P) for large operable breast cancer: A very active new regimen

✍ Jones, AL; Smith, IE; Walsh, G; Baum, M; Sacks, N 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Neoadjuvant sequential epirubicin and do

Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer

✍ Panteleimon Kountourakis; Ioannis Missitzis; Dimitrios Doufexis; Vassileios Zobo 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 281 KB

A nonreplicating adenoviral vector that

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer : Safety, efficacy, and biologic activity of a novel gene-therapy approach

✍ Massimo Cristofanilli; Savitri Krishnamurthy; Laura Guerra; Kristine Broglio; Ba 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 1 views